CONMED Corp (NYSE: CNMD) has reported E.P.S. of $0.64 for its first fiscal quarter (ending March 31) versus $0.06 for the same period a year ago. For the latest four quarters through March 31, E.P.S. were $2.69 versus $-3.21 for the same period a year ago.
Recent Price Action
CONMED Corp (NYSE: CNMD) stock declined modestly by -1.8% on 4/24/24. The stock closed at $70.01. Moreover, exceptionally high trading volume at 247% of normal accompanied the decline. The stock has been extremely weak relative to the market over the last nine months and has declined -9.6% during the last week.
Current PriceTarget Research Rating
CNMD is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
CONMED has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. CONMED has a slightly negative Appreciation Score of 34 and a very low Power Rating of 12, triggering the Lowest Value Trend Rating.
Rating Review
In light of this new information and negative market action we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment